Clinical Trial Update: Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus

View source ↗

Summary

An observational prospective study evaluating acalabrutinib for chronic lymphocytic leukemia in real clinical practice in Belarus is ongoing, sponsored by Astra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CALQUENCE (ACALABRUTINIB)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Lymphocytic Leukemia | Status: RECRUITING